The International journal of pharmacy practice · 2026
Formulary optimization to reduce the carbon footprint of inhalers in a tertiary hospital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Doherty Iarlaith, Yadav Ankit, Vaughan Marguerite, McGillycuddy Joan, McConville Darren, Fitzgerald Deirdre
Аннотация
OBJECTIVES: To reduce the carbon footprint of inhalers by formulary optimization.
METHODS: The carbon footprint of inhalers dispensed in 2023 was audited.The preferred salbutamol metered dose inhaler was changed in March 2024. After 5 months, a second audit was done to assess this intervention.
KEY FINDINGS: The carbon footprint was 109 tonnes of CO2 equivalents in 2023. Metered dose inhalers accounted for 97.8% of emissions (107 t CO2 equivalents) but only 55% (n = 4149) of inhalers dispensed.Following the intervention, monthly emissions were significantly lower (P = .048).
CONCLUSIONS: Inhaler formulary optimization significantly reduced the carbon footprint.
METHODS: The carbon footprint of inhalers dispensed in 2023 was audited.The preferred salbutamol metered dose inhaler was changed in March 2024. After 5 months, a second audit was done to assess this intervention.
KEY FINDINGS: The carbon footprint was 109 tonnes of CO2 equivalents in 2023. Metered dose inhalers accounted for 97.8% of emissions (107 t CO2 equivalents) but only 55% (n = 4149) of inhalers dispensed.Following the intervention, monthly emissions were significantly lower (P = .048).
CONCLUSIONS: Inhaler formulary optimization significantly reduced the carbon footprint.